Abstract

Intestinal microbiota-derived metabolites have biological importance for the host. Polyamines, such as putrescine and spermidine, are produced by the intestinal microbiota and regulate multiple biological processes. Increased colonic luminal polyamines promote longevity in mice. However, no direct evidence has shown that microbial polyamines are incorporated into host cells to regulate cellular responses. Here, we show that microbial polyamines reinforce colonic epithelial proliferation and regulate macrophage differentiation. Colonisation by wild-type, but not polyamine biosynthesis-deficient, Escherichia coli in germ-free mice raises intracellular polyamine levels in colonocytes, accelerating epithelial renewal. Commensal bacterium-derived putrescine increases the abundance of anti-inflammatory macrophages in the colon. The bacterial polyamines ameliorate symptoms of dextran sulfate sodium-induced colitis in mice. These effects mainly result from enhanced hypusination of eukaryotic initiation translation factor. We conclude that bacterial putrescine functions as a substrate for symbiotic metabolism and is further absorbed and metabolised by the host, thus helping maintain mucosal homoeostasis in the intestine.

Polyamines produced by intestinal bacteria are thought to have beneficial effects on the host. Here the authors show that these polyamines increase regulatory macrophage abundance and are taken up by colonic epithelial cells to enhance colonic barrier function and immunity in mice.

Details

Title
Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon
Author
Nakamura, Atsuo 1   VIAFID ORCID Logo  ; Kurihara Shin 2 ; Takahashi, Daisuke 3   VIAFID ORCID Logo  ; Ohashi Wakana 3 ; Nakamura, Yutaka 3 ; Kimura Shunsuke 4 ; Onuki Masayoshi 3 ; Kume Aiko 5 ; Sasazawa Yukiko 6 ; Furusawa Yukihiro 7 ; Obata Yuuki 8   VIAFID ORCID Logo  ; Fukuda Shinji 9   VIAFID ORCID Logo  ; Saiki Shinji 6 ; Matsumoto Mitsuharu 10   VIAFID ORCID Logo  ; Hase Koji 11   VIAFID ORCID Logo 

 Keio University, Minato-ku, Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); Kyodo Milk Industry Co., Ltd., Hinode-machi, Nishitama-gun, Dairy Science and Technology Institute, Tokyo, Japan (GRID:grid.26091.3c) 
 Ishikawa Prefectural University, Faculty of Bioresources and Environmental Sciences, Nonoichi, Japan (GRID:grid.410789.3) (ISNI:0000 0004 0642 295X); Kindai University, Faculty of Biology-Oriented Science and Technology, Kinokawa, Japan (GRID:grid.258622.9) (ISNI:0000 0004 1936 9967) 
 Keio University, Minato-ku, Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959) 
 Keio University, Minato-ku, Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); PRESTO, Japan Science and Technology Agency, Kawaguchi, Japan (GRID:grid.419082.6) (ISNI:0000 0004 1754 9200) 
 Kyodo Milk Industry Co., Ltd., Hinode-machi, Nishitama-gun, Dairy Science and Technology Institute, Tokyo, Japan (GRID:grid.26091.3c) 
 Juntendo University, Bunkyo-ku, Department of Neurology, Graduate School of Medicine, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738) 
 Keio University, Minato-ku, Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); Toyama Prefectural University, Department of Liberal Arts and Sciences, Kurokawa, Japan (GRID:grid.412803.c) (ISNI:0000 0001 0689 9676) 
 Keio University, Minato-ku, Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); The Francis Crick Institute, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830) 
 PRESTO, Japan Science and Technology Agency, Kawaguchi, Japan (GRID:grid.419082.6) (ISNI:0000 0004 1754 9200); Keio University, Institute for Advanced Biosciences, Tsuruoka, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); University of Tsukuba, Transborder Medical Research Center, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); Kanagawa Institute of Industrial Science and Technology, Intestinal Microbiota Project, Kawasaki, Japan (GRID:grid.20515.33) 
10  Kyodo Milk Industry Co., Ltd., Hinode-machi, Nishitama-gun, Dairy Science and Technology Institute, Tokyo, Japan (GRID:grid.258269.2) 
11  Keio University, Minato-ku, Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); The University of Tokyo (IMSUT), Bunkyo-ku, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2509906522
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.